Supply Chain

The world continues to reel from the pandemic and, among many other things, the shortage of medical supplies that has resulted. Yes, the world has experienced natural disasters, but they are typically limited in time duration and location. The coronavirus pandemic has severely impacted the globe for many months.

f you've ever taken advantage of a nice discount thanks to a promotion from Groupon or LivingSocial, you've tapped the power of the daily deal market yourself. You, the consumer, benefited from the prior bargaining that took place between that big online platform and the merchant, resulting in a lower price for you.

The COVID 19 has caused unprecedented havoc in the world and disrupted lives, livelihood, business, enterprise, and economy. The disruption to the supply chain and the inadequate response of the industry has been the cause of concern across the globe.

We do not yet have a vaccine that can be used to help protect people from contracting COVID-19. However, once a vaccine is proven to be both safe and effective, governments, industry and healthcare providers will face the considerable task of figuring out how to distribute the vaccine fairly and efficiently.

Four months into the coronavirus pandemic, and the race to find disinfectant wipes continues. “I figured the rush would be over and people would relax a little bit, but I think they’re still hoarding,” Sean Sphisak, a shopper, said. “There’s none,” Angel Gonzalez, another shopper, said. “I’ve gone to all these grocery stores. I’ve gone to Rite Aid, CVS, anything you can think of, I’ve been there.”

On Friday, Democratic Senators Elizabeth Warren of Massachusetts and Cory Booker of New Jersey released the findings of their June investigation into why America’s biggest meat companies warned of domestic shortages while at the same time exporting record quantities of meat to China during the height of pandemic-related supply chain backups in April.

The shortage of personal protective equipment (PPE) in the U.S.—which has exacerbated the COVID-19 crisis across the country—is likely to continue in a second wave of the pandemic. It has also exposed supply chain vulnerabilities in the process, namely, the reliance on foreign countries to produce the overwhelming majority of specialized PPE, such as N95 masks. 

The COVID-19 pandemic has been deeply disruptive for supply chains as businesses grapple with fluctuations in supply and demand, intermittent outbreaks in different parts of the world, and speculation about reshoring and reducing reliance on China. Many companies are looking at restructuring their supply chains, trying to balance resilience with efficiency and reduced costs — a process either started or accelerated because of the pandemic.

The Covid-19 pandemic exposed vulnerabilities in global supply chains of medical supplies, which stoked public fear over shortages of essential medicines and medical supplies. As the world is focusing on the development of vaccines to combat the latest coronavirus, we shall not lose sight of the delivery of these vaccines, especially when there is a lack of a coordinated medical supply chain in the U.S.

Behind the news about resurging coronavirus cases and the debate about wearing face coverings in the U.S., a global race is underway to develop Covid-19 vaccine to quell the pandemic. As of July 15, 2020, there were 163 vaccines against the coronavirus and 23 of them were undergoing human trials. Before this race ends, we must start thinking about the endgame. The underlying health risks have prompted the U.S. government to promise delivery of 300 million doses of Covid-19 vaccine by January 2021 under Operation Warp Speed.